Frank L. Douglas

Advancing Drug Innovation for Neglected Diseases—Criteria for Lead Progression

Solomon Nwaka, Bernadette Ramirez, Reto Brun et al. · PLoS neglected tropical diseases · 2009 · 195 citations · Full text

Pharmacy, Medicinal Chemistry, Drug Design +14

Building Organizational and Scientific Platforms in the Pharmaceutical Industry: A Process Perspective on the Development of Dynamic Capabilities

V. K. Narayanan, Ken Colwell, Frank L. Douglas · British Journal of Management · 2009 · 141 citations

Management, Organizational Behavior, Strategic Management +12

Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.

Michael Murphy, C E McCoy, Roy R. Weber et al. · Circulation · 1987 · 115 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Treatment of malignant pheochromocytoma with combination chemotherapy.

Harry R. Keiser, D. S. Goldstein, James L. Wade et al. · Hypertension · 1985 · 105 citations

Medicine, Oncology, Pharmacology +11

Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels.

Sol I. Rajfer, James D. Rossen, Frank L. Douglas et al. · Circulation · 1986 · 84 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17